Yakup Ergün, Medical Oncologist at Bower Hospital, shared an article by V. Tuninetti, Oncologist at Mauriziano Hospital in Turin, on X:
” A great article discussing the optimal use of PARP inhibitors, their re-use after progression, and the relationship between their duration of use and the incidence of hematological malignancies.“
Authors: V. Tuninetti, et al.
